WPI 1119 (Mirtazapine 45 mg)

Pill with imprint WPI 1119 is White, Elliptical / Oval and has been identified as Mirtazapine 45 mg. It is supplied by Watson Pharmaceuticals.

Mirtazapine is used in the treatment of major depressive disorder; insomnia; anxiety; depression; hot flashes (and more), and belongs to the drug class tetracyclic antidepressants. Risk cannot be ruled out during pregnancy. Mirtazapine 45 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 1119

Save up to 80% off prescription medications

Click here for your free Discount Card

Mirtazapine

Imprint:

WPI 1119

Strength:

45 mg

Color:

White

Size:

16.00 mm

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Tetracyclic antidepressants

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Labeler / Supplier:

Watson Pharmaceuticals

Inactive Ingredients:

lactose anhydrous
silicon dioxide
magnesium stearate
microcrystalline cellulose
hypromellose 2910 (3 mPa.s)
hypromellose 2910 (6 mPa.s)
polyethylene glycol 400
polysorbate 80
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC Code	Labeler / Repackager
63874-1155	Altura Pharmaceuticals Inc. (repackager)

More Info Imprint SearchPrint

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.